-
Founded in:
1994-01-26 -
Country:
China -
Address:
Jiangtong Road, Xingyun Street, Jiangchuan District, Yuxi City, Yunnan Province -
Tax NO.:
91530421577261520F -
Registered Funds:
11 million yuan -
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Semen Plantaginis |
|
0 | ||
| Anemarrhena(Salt) |
|
0 | ||
| Motherwort Herb P.E. |
|
0 | ||
| Rhubarb (processed) |
|
0 | ||
| Gardeniae Fructus |
|
0 | ||
| PHELLODENDRINE CHLORIDE |
|
104112-82-5 | 0 | |
| MOUTAN CORTEX |
|
0 | ||
| DGL |
|
0 | ||
| Aconite (roasted) |
|
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Kidney tea |
|
0 | ||
| Xiao Yan |
|
0 | ||
| Imperatae Rhizoma |
|
0 | ||
| Phellodendri Chinensis Cortex |
|
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Coriander leaf extract |
Not yet clear
More
Not yet clear |
0 | ||
| Platycodonis Radix |
Not yet clear
More
Not yet clear |
0 | ||
| Radix Pseudostellariae powder |
Not yet clear
More
Not yet clear |
0 | ||
| STEMONAE RADIX |
Not yet clear
More
Not yet clear |
0 | ||
| PAPAVERIS PERICARPIUM |
Not yet clear
More
Not yet clear |
0 | ||
| Ephedra |
Not yet clear
More
Not yet clear |
0 | ||
| VITICIS NEGUNDINIS FRUCTUS |
Not yet clear
More
Not yet clear |
0 | ||
| Adenophorae Radix |
Not yet clear
More
Not yet clear |
0 | ||
| Andrographolide |
Not yet clear
More
Not yet clear |
5508-58-7 | 6 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Kidney tea |
|
0 | ||
| Xiao Yan |
|
0 | ||
| Imperatae Rhizoma |
|
0 | ||
| Phellodendri Chinensis Cortex |
|
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Gemfibrozil |
This product is a lipid-regulating drug of the clofibric acid derivative class. Its mechanism of action in lowering blood lipids is not yet fully understood. It may involve peripheral fat decomposition, reduce the liver's uptake of free fatty acids and reduce the formation of triglycerides in the liver, inhibit the synthesis of very low-density lipoprotein apolipoproteins and reduce the production of very low-density lipoproteins. This product reduces blood triglycerides and increases blood high-density lipoprotein concentrations. Although it can slightly reduce blood low-density lipoprotein cholesterol blood concentrations, it may increase low-density lipoprotein in type IV hyperlipoproteinemia. A 5-year placebo-controlled study showed that this product can reduce the occurrence of severe coronary heart disease sudden death and myocardial infarction. Long-term administration of 10 times the human dose to rats increased the incidence of liver malignancies and benign testicular tumors.
More
This product is a lipid-regulating drug of the clofibric acid derivative class. Its mechanism of action in lowering blood lipids is not yet fully understood. It may involve peripheral fat decomposition, reduce the liver's uptake of free fatty acids and reduce the formation of triglycerides in the liver, inhibit the synthesis of very low-density lipoprotein apolipoproteins and reduce the production of very low-density lipoproteins. This product reduces blood triglycerides and increases blood high-density lipoprotein concentrations. Although it can slightly reduce blood low-density lipoprotein cholesterol blood concentrations, it may increase low-density lipoprotein in type IV hyperlipoproteinemia. A 5-year placebo-controlled study showed that this product can reduce the occurrence of severe coronary heart disease sudden death and myocardial infarction. Long-term administration of 10 times the human dose to rats increased the incidence of liver malignancies and benign testicular tumors. |
25812-30-0 | 14 |